Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
6,321,313
-
Share change
-
+1,768,095
-
Total reported value
-
$426,561,742
-
Put/Call ratio
-
5.5%
-
Price per share
-
$67.24
-
Number of holders
-
85
-
Value change
-
+$118,107,484
-
Number of buys
-
36
-
Number of sells
-
36
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q3 2022
As of 30 Sep 2022 VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) had 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,321,313 shares of stock of the company.
Largest 10 holders included Phoenix Holdings Ltd., GOLDMAN SACHS GROUP INC, UBS Group AG, Noked Israel Ltd, Noked Capital LTD, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SNC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, and CITADEL ADVISORS LLC.
This table shows 85 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.